ArticleBMC psychiatry2026
Assessment of treatment outcomes among bipolar patients at Mathari National Teaching and Referral Hospital, Kenya.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBipolar disorder (BD) is a chronic psychiatric illness associated with significant morbidity and functional impairment. Although symptom control is a key goal of pharmacological treatment, functional recovery often remains elusive. In sub-Saharan Africa, and particularly Kenya, limited data exist on treatment outcomes for BD. This study assessed remission, functional recovery, and suicidality among bipolar patients at Mathari National Teaching and Referral Hospital, Kenya’s primary mental health institution.
methodsA cross-sectional descriptive design was carried out among 51 adult patients diagnosed with BD (Type I or II) and treated for at least 6 months. Manic and depressive symptoms were assessed at the time of evaluation by using the Young Mania Rating Scale (YMRS) and Hamilton Depression Rating Scale (HAM-D); functional outcomes were measured using the Functioning Assessment Short Test (FAST). Suicidality was assessed through structured clinical interview questions.
resultsApproximately 92.2% scored below the threshold for clinically significant manic symptoms at the time of assessment, and 74.5% for depression. However, only 45.1% achieved functional recovery (FAST score < 11). Occupational and interpersonal functioning were the most impaired domains. Suicidal thoughts or behaviors were reported by a minority of participants. Specifically, 15.7% (n = 8) reported suicidal ideation and 5.9% (n = 3) reported a history of suicide attempt.
conclusionsEven though a high proportion of participants scored below symptomatic thresholds, indicating low current symptom burden, substantial functional impairment persisted, underscoring the need for integrative treatment strategies targeting psychosocial and occupational domains in BD management. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.